Detailed information for compound 980719

Basic information

Technical information
  • TDR Targets ID: 980719
  • Name: 4-methyl-N-(4-pyridin-2-yl-1,3-thiazol-2-yl)p yridin-2-amine
  • MW: 268.337 | Formula: C14H12N4S
  • H donors: 1 H acceptors: 3 LogP: 3.08 Rotable bonds: 3
    Rule of 5 violations (Lipinski): 1
  • SMILES: Cc1ccnc(c1)Nc1scc(n1)c1ccccn1
  • InChi: 1S/C14H12N4S/c1-10-5-7-16-13(8-10)18-14-17-12(9-19-14)11-4-2-3-6-15-11/h2-9H,1H3,(H,16,17,18)
  • InChiKey: QMEBVRXZLKAAIG-UHFFFAOYSA-N  

Network

Hover on a compound node to display the structore

Synonyms

  • 4-methyl-N-[4-(2-pyridyl)thiazol-2-yl]pyridin-2-amine
  • 4-methyl-N-[4-(2-pyridyl)-2-thiazolyl]-2-pyridinamine
  • (4-methyl-2-pyridyl)-[4-(2-pyridyl)thiazol-2-yl]amine
  • ST072426
  • (4-Methyl-pyridin-2-yl)-(4-pyridin-2-yl-thiazol-2-yl)-amine
  • ZINC00088330
  • BAS 08770269

Targets

Known targets for this compound

Species Target name Source Bibliographic reference
Homo sapiens potassium intermediate/small conductance calcium-activated channel, subfamily N, member 1 Starlite/ChEMBL References
Homo sapiens potassium intermediate/small conductance calcium-activated channel, subfamily N, member 3 Starlite/ChEMBL References
Homo sapiens potassium intermediate/small conductance calcium-activated channel, subfamily N, member 2 Starlite/ChEMBL References

Predicted pathogen targets for this compound

By orthology
Species Potential target Known druggable target/s Ortholog Group
Loa Loa (eye worm) hypothetical protein Get druggable targets OG5_130097 All targets in OG5_130097
Schistosoma japonicum IPR011996,SK channel region,domain-containing Get druggable targets OG5_130097 All targets in OG5_130097
Loa Loa (eye worm) hypothetical protein Get druggable targets OG5_130097 All targets in OG5_130097
Schistosoma mansoni hypothetical protein Get druggable targets OG5_130097 All targets in OG5_130097
Schistosoma japonicum Small conductance calcium-activated potassium channel protein, putative Get druggable targets OG5_130097 All targets in OG5_130097
Echinococcus multilocularis small conductance calcium activated potassium Get druggable targets OG5_130097 All targets in OG5_130097
Schistosoma japonicum ko:K04942 potassium intermediate/small conductance calcium-activated channel,, putative Get druggable targets OG5_130097 All targets in OG5_130097
Schistosoma japonicum expressed protein Get druggable targets OG5_130097 All targets in OG5_130097
Schistosoma mansoni calcium-activated potassium channel Get druggable targets OG5_130097 All targets in OG5_130097
Schistosoma japonicum Small conductance calcium-activated potassium channel protein, putative Get druggable targets OG5_130097 All targets in OG5_130097
Schistosoma japonicum ko:K01047 phospholipase A2 [EC3.1.1.4], putative Get druggable targets OG5_130097 All targets in OG5_130097
Echinococcus granulosus small conductance calcium activated potassium Get druggable targets OG5_130097 All targets in OG5_130097

By sequence similarity to non orthologous known druggable targets
Species Potential target Known druggable target Length Alignment span Identity
Plasmodium vivax hypothetical protein, conserved potassium intermediate/small conductance calcium-activated channel, subfamily N, member 2 231 aa 188 aa 21.3 %

Obtained from network model

Ranking Plot


Putative Targets List


Species Potential target Raw Global Species
Schistosoma mansoni calcium-activated potassium channel 0.0366 0.5365 0.5365
Schistosoma mansoni hypothetical protein 0.0615 1 1
Schistosoma mansoni calcium-activated potassium channel 0.0615 1 1
Brugia malayi Calcitonin receptor-like protein seb-1 0.0115 0.0681 1
Loa Loa (eye worm) hypothetical protein 0.0238 0.2972 0.2972
Loa Loa (eye worm) hypothetical protein 0.0615 1 1
Loa Loa (eye worm) hypothetical protein 0.0225 0.2732 0.2732
Loa Loa (eye worm) pigment dispersing factor receptor c 0.0115 0.0681 0.0681
Loa Loa (eye worm) hypothetical protein 0.0115 0.0681 0.0681
Brugia malayi Corticotropin releasing factor receptor 2 precursor, putative 0.0115 0.0681 1
Loa Loa (eye worm) hypothetical protein 0.0128 0.0921 0.0921
Echinococcus multilocularis small conductance calcium activated potassium 0.0615 1 0.5

Activities

Activity type Activity value Assay description Source Reference
CC50 (ADMET) = 31.1 uM Cytotoxicity in human KB cells assessed as cell viability incubated for 72 hrs by MTT assay ChEMBL. 26318065
IC50 (binding) = 0.004 uM Displacement of [125I]apamin from Kca2.3 channel expressed in HEK293 cells by scintillation proximity assay ChEMBL. 18774291
IC50 (binding) = 0.004 uM Inhibition of Kca2.1 channel expressed in HEK293 cells by thallium flux assay ChEMBL. 18774291
IC50 (binding) = 0.011 uM Inhibition of Kca2.2 channel expressed in HEK293 cells by thallium flux assay ChEMBL. 18774291
IC50 (binding) = 0.056 uM Inhibition of Kca2.3 channel expressed in HEK293 cells by electrophysiology assay ChEMBL. 18774291
IC50 (binding) = 0.059 uM Inhibition of Kca2.3 channel expressed in HEK293 cells by thallium flux assay ChEMBL. 18774291
IC50 (binding) = 0.059 uM Displacement of [125I]apamin from Kca2.2 channel expressed in HEK293 cells ChEMBL. 18774291
IC50 (functional) = 0.7 uM Antileishmanial activity against Leishmania donovani MHOM/IN/80/Dd8 expressing luciferase reporter gene infected in mouse J-774A1 cells assessed as inhibition of amastigote stage formation incubated for 72 hrs by luminometry ChEMBL. 26318065
Inhibition (binding) = 10 % Inhibition of Kca3.1 channel expressed in HEK293 cells at 30 uM by thallium flux assay ChEMBL. 18774291
Inhibition (binding) = 98 % Inhibition of Kca2.3 channel expressed in HEK293 cells at 30 uM by thallium flux assay ChEMBL. 18774291

Phenotypes

Whole-cell/tissue/organism interactions

Species name Source Reference Is orphan
Leishmania donovani ChEMBL23 26318065

Many chemical entities in TDR Targets come from high-throughput screenings with whole cells or tissue samples, and not all assayed compounds have been tested against a single a single target protein, probably because they get ruled out during screening process. Even if these compounds may have not been of interest in the original screening, they may come as interesting leads for other screening assays. Furthermore, we may be able to propose drug-target associations using chemical similarities and network patterns.

Annotated phenotypes:

We have no manually annotated phenotypes for this drug. What does this mean? / Care to help?
In TDR Targets, information about phenotypes that are caused by drugs, or by genetic manipulation of cells (e.g. gene knockouts or knockdowns) is manually curated from the literature. These descriptions help to describe the potential of the target for drug development. If no information is available for this gene or if the information is incomplete, this may mean that i) the papers containing this information either appeared after the curation effort for this organism was carried out or they were inadvertently missed by curators; or that ii) the curation effort for this organism has not yet started.
 
In any case, if you have information about papers containing relevant validation data for this target, please log in using your TDR Targets username and password and send them to us using the corresponding form in this page (only visible to registered users) or contact us.

External resources for this compound

Bibliographic References

1 literature reference was collected for this gene.

If you have references for this compound, please enter them in a user comment (below) or Contact us.